|
|
| |
 |
Personal protective equipment in an influenza pandemic: a UK simulation exercise
From J Hosp Infect, published online Nov 17
|
|
|
Avian influenza: a global threat needing a global solution
Commentary from Asia Pacific Fam Med, published online Nov 13
|
|
|
Respirator-fit testing: does it ensure the protection of healthcare workers against respirable particles carrying pathogens?
From Infect Control Hosp Epidemiol, published online Nov 3
|
|
|
Safety and immunogenicity of a prepandemic influenza A (H5N1) vaccine
From Pediatr Infect Dis J, published online Oct 30
|
|
|
Would an influenza pandemic qualify as a major disaster under the Stafford Act?
|
|
|
Vaccination strategies and vaccine formulations for epidemic and pandemic influenza
From Hum Vaccines, published online Oct 30
|
|
|
Antiviral therapy for avian influenza virus (H5N1) infection at 2 Thai medical centers: survey findings and implications for pandemic preparedness
From Infect Control Hosp Epidemiol, published online Oct 30
|
|
|
The international response to highly pathogenic avian influenza: science, policy and politics
STEPS Centre report released Oct 23
|
|
|
Blueprint for a healthier America: modernizing the federal public health system to focus on prevention and preparedness
Report from Trust for America's Health released Oct 21
|
|
|
National strategy for pandemic influenza implementation plan: two year summary
Released Oct 17 by the White House Homeland Security Council
|
|
|
Pandemic: potential insurance impacts
Report from Lloyd's Insurance released Oct 17
|
|
|
Evaluating the economic consequences of avian influenza
|
|
|
Modeling the economic impact of pandemic influenza: a case study in Turkey
From J Med Syst, published online Oct 14
|
|
|
An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines
|
|
|
Structural characterization of the 1918 influenza virus H1N1 neuraminidase
|
|
|
Pandemic preparedness in the states: an assessment of progress and opportunity
Recent report from the National Governors Association
|
|
|
Simulation exercises on influenza pandemic responses in the Asia-Pacific region
Oct report from UN System Influenza Coordinator
|
|
|
Responses to avian influenza and state of pandemic readiness: fourth global progress report
From UN System Influenza Coordinator & World Bank, released Oct 15
|
|
|
Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1
Letter from Oct 9 N Engl J Med
|
|
|
Insights into inflammation and influenza
|
|
|
Pandemic Influenza
CIDRAP-authored overview, updated Oct 3 with new research
|
|
|
Influenza pandemic: HHS needs to continue its actions and finalize guidance for pharmaceutical interventions
GAO report released Sep 30
|
|
|
Public health emergency preparedness: six years of achievement
Sep 29 document from ASTHO, APHL, CSTE, and NACCHO
|
|
|
Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as human vaccines
WHO document updated Sep 29
|
|
|
Avian influenza A (H5N1) and pandemic influenza
State Department fact sheet updated Sep 27
|
|
|
H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 viruses
|
|
|
Pandemic influenza and excess intensive-care workload
From Emerg Infect Dis, published online Sep 25
|
|
|
Resource allocation during an influenza pandemic
Letter from Emerg Infect Dis, published online Sep 25
|
|
|
Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial
From J Infect Dis, published online Sep 22
|
|
|
Cross-protection between successive waves of the 1918-1919 influenza pandemic: epidemiological evidence from US Army camps and from Britain
From J Infect Dis, published online Sep 22
|
|
|
Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans
From Lancet Infect Dis, published online Sep 22
|
|
|
WHO: Confirmed Human Cases of Avian Influenza A (H5N1)
|
|
